Veracuity joins COVID-19 Evidence Accelerator
In April 2020, the Veracuity team developed a survey tool for the collection of data from hospitalized COVID19 patients. This initiative was implemented and widely distributed by the Alliance for Clinical Research Excellence and Safety (ACRES). At the recommendation of the Principal Deputy Commissioner of Food and Drugs, Amy P. Abernethy, M.D., Ph.D., Veracuity joined the COVID-19 Evidence Accelerator, organized by the Reagan-Udall Foundation for the FDA in collaboration with Friends of Cancer Research. The scarcity of evidence and ambiguity
Veracuity May 1, 2020 No Comments